Utilized for glaucoma to manage intraocular pressure and support vision maintenance.
Mechanism of Action
Travoprost is a synthetic prostanoid FP receptor agonist that increases the uveoscleral outflow of aqueous humor from the eye, effectively reducing internal pressure and preventing optic nerve damage.
Route of Administration
Ophthalmic
Onset Time
2 hours
Duration
24 hours
Contraindications
Hypersensitivity to travoprost, Hypersensitivity to benzalkonium chloride
Severe Adverse Events
Macular edema, Uveitis, Anaphylaxis — requires immediate medical attention
Common Side Effects
Eye redness, Itching, Blurred vision
Uncommon Side Effects
Iris color change, Eyelash growth, Eye pain
Drug Interactions
Alcohol, Latanoprost, Bimatoprost
Pregnancy Safety Warnings
FDA Category C: Use only if potential benefit outweighs risk. Breastfeeding: Excretion in milk is unknown.
Age Restrictions
Safety and efficacy established in pediatric patients of all ages.
Information related to Travatan is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
